Tff peptides are secreted mainly by the gastrointestinal epithelial cells and their primary role is maintaining normal structure and function of mucous epithelia. Ongoing studies on their expression pattern have disclosed other sites of their synthesis thus revealing additional physiological functions in the organism. Here we present new data about Tff3 expression in the cochlea of the rodent inner ear. On the basis of RT-PCR we describe the presence of Tff3 transcripts in both, a mouse cDNA library isolated from whole cochleae from postnatal days 3-15 (P3-P15), and also in cochlear tissue. By using a riboprobe for the fragment containing exon 1, 2 and 3 of Tff3, in situ hybridization, localized Tff3 signals in neurons of spiral ganglion and vestibular organ. We did not observe any abnormalities in the middle ear of Tff3 knock-out mice, neither did histological examination of the inner ear indicate any gross morphological changes in the cochlea. However, ABR (auditory evoked brain stem responses) audiograms revealed that the Tff3 knock-out animals show an accelerated presbyacusis and a hearing loss of about 15 dB at low frequencies increasing to 25 dB loss at higher frequencies. These findings suggest that Tff3 could play a role in neurosensory signaling. Further studies are needed to clarify this new function in the auditory system.
Introduction
Trefoil factor family (TFF) peptides were originally noted to be secreted from mucin-producing epithelial cells of the gastrointestinal tract where they play an essential role in maintaining surface integrity. The protective mechanisms involved include at least stabilization of the mucus barrier, enhancement of rapid mucosal repair by restitution (motogenic activity, anti-apoptotic properties, modulation of cell-cell contacts), and modulation of mucosal differentiation processes [1] [2] [3] [4] . TFF secretion was furthermore established in additional epithelia such as in the uterus, biliary tract, respiratory tract, and salivary glands [1, 5, 6] . Each of the three TFF members 
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(TFF1-3) displays a tissue-specific expression pattern which, moreover, becomes shifted in neoplastic development [7] .
A major source for TFF3 (formerly intestinal trefoil factor/ITF/rP1.B) synthesis are goblet cells of the small and large intestine. While it was observed that Tff3 expression in the mouse is not directly correlated with the number of goblet cells [8] , its secretion is evoked by certain inflammatory mediators and neurotransmitters [9] . Abundant TFF3 synthesis has also been noted in goblet cells of the conjunctiva, contributing, together with TFF1, to the eye's tear fluid and protective mucus [10] . In addition to these epithelia-related functions of TFFs an intriguing new function appears to arise from several reports pointing to Tff1 expression in perinatal rat hippocampus [11] and Tff3 synthesis in the rat and human hypothalamus [12, 13] . The presence of the latter exclusively in oxytocinergic neurons but not in vasopressinergic neurons suggested its role as neuropeptide acting together with oxytocin along the hypothalamo-pituitary axis [14] . Tff3 originating from the posterior pituitary showed retarded electrophoretic mobility compared with duodenal Tff3, most likely due to an unknown posttranslational modification [1] . By injection of Tff3 into the basolateral nucleus of the rat amygdala, this peptide induced differential behavioral effects [15] . These features and Tff3's presence in supraoptic nuclei [11] suggested assessing the trefoil peptides' possible presence and functioning in cells of the neurosensory tissue. However, the major site of Tff3 expression in murine brain is the cerebellum [16] . TFFs are proteins that participate in mucosal healing and show modulated expression in inflammatory diseases and neoplastic progression. In various inflammatory diseases as ulcerative colitis (UC), gastric ulcer disease and Morbus Crohn an aberrant expression of trefoils was observed [1] . This enhanced expression has been associated to ulcer associated cell lineage (UACL) which develops from the glands/crypts adjacent to the ulcer [17] . Ulcerative colitis has been considered as a chronic disorder characterized by an inflammation and limited to the colonic mucosa. However, there is increasing evidence that UC may also manifest in the peripheral (PNS) and in the central nervous system (CNS). Among major pathogenic entities a cereberal demyelination, immune mediated neuropathy and sensorineural hearing loss have been differentiated [18] . It is known that Tffs are important for mucosal healing. Chronic inflammatory condition, resulting from disturbance in the healing process, is associated with strong expression of many pro-and anti-inflammatory cytokines that regulate Tffs expression [19, 20] . The inhibitory effect of proinflammatory cytokines on TFF2 and particularly TFF3 [21] has been further evaluated. It was shown that Tff3 is strongly down-regulated by TNFα and NFκB in a case of inflammatory bowel disease [19] whereas TFF1 and TFF2 were up-regulated [17] . It was also indicated that TFF3 was downregulated in UC tissues [22] . Additional information about possible manifestation of UC on the neurological level makes it interesting to analyze if trefoil peptides are present in the inner ear and involved in the hearing process.
Here, we investigated the cochlea of the rodent inner ear for the presence of Tff3 peptide and analysed its role for hearing function in Tff3 deficient mice.
Materials and Methods

Animals
Tff3 deficient animals described previously [23] were obtained from Prof. D.K. Podolsky (Harvard Medical School). These animals were backcrossed to C57BL/6 and to 129/Sv mice leading to a mixed background. Tff3 homozygous sister lines were established representing a Tff3 deficient genotype (Tff3 -/-) and a wild-type (Tff3 +/+), respectively. Care and use of the animals and the experimental protocol were reviewed and approved by the animal welfare commissioner and the regional board for scientific animal experiments (Regierungspräsidium Tübingen). Animals were sacrificed by decapitation and cochleae were removed according to national ethical guidelines.
RNA isolation and RT-PCR
By homogenizing a 5 mm colon section and 6 isolated cochleae from Tff3 wild-type/knock-out mice and a stomach section of Tff2 wild-type/knock-out mice a total RNA was isolated with the RNeasy Mini Kit (Qiagen). 500 ng of RNA was transcribed into cDNA (iScript cDNA Synthesis Kit; Bio-Rad). A cDNA library generated from mouse whole cochleae, postnatal days 3-15 (P3-P15) (a generous gift from R. J. H. Smith, University of Iowa) was also used. A 167-bp fragment of Tff3 was amplified with mTff3_3For: 5'-AAC CGT GGC TGC TGC TTT-3' and mTff3_3Rev: 5'-CCT GGA GCC TGG ACA GCT T-3' primer pair. Since the expression of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was stable in the colon, stomach (positive controls) and cochlea we used it as an internal control. A 200-bp fragment was amplified with: mGAPDH_4For: 5'-AAC GAC CCC TTC ATT GAC-3' and mGAPDH_4Rev: 5'-TCC ACG ACA TAC TCA GCA C-3' primer pair. The PCR conditions were: denaturation at 95°C for 3min, followed by 35 cycles at 95°C for 25 sec, 59°C for 20 sec and 72°C for 1min. The analysis was performed in triplicate in at least three animals. The resulting PCR-products were analyzed on ethidium bromide agarose gels.
Preparation of the cochlea spiral
Tff3 wild-type and knock-out mice were decapitated following anaesthesia with carbon dioxide. The bullae were removed and the cochlear spiral was dissected in Hanks' Balanced Salt Solution (HBSS), pH 7.4, with 1mM protease inhibitor (Pefabloc, Roth).
Histological preparation of the cochleae and toluidin blue staining
Briefly, isolated cochleae were fixed by immersion for 2 hours in 2% paraformaldehyde (PFA, SIGMA-Aldrich), decalcified in EDTA (0.35 M) and post fixed in osmium tetroxide. After dehydration in solutions of ethanol at increasing concentrations cochleae were embedded in epoxy resin embedding medium (EPON). Serial sections of 10 ìm were stained with 1 % toluidine blue. Analysis was performed under transmitted light illumination. Sections were photographed using an Olympus AX-70 microscope. Representative images were chosen for presentation.
Tissue preparation of the cochlea for in situ hybridization
Briefly, isolated cochlea were fixed by immersion in 2% paraformaldehyde (PFA, SIGMA-Aldrich, all chemicals from SIGMA-Aldrich, unless indicated otherwise), 125 mM sucrose in 100 mM phosphate buffered saline (PBS), pH 7.4, for 2 hours, followed by overnight incubation in 25 % sucrose in PBS, pH 7.4. Cochleae were then embedded in O.C.T. compound (Miles Laboratories), cryosectioned at 10 µm thickness for in situ hybridization, mounted on SuperFrost * /plus microscope slides, dried for 1 hour, and stored at -20°C before use.
Riboprobe synthesis and in situ hybridization
Using the oligonucleotide primer pair For1: TGT GCA GTG GTC CTG AAG CTT and Rev1: GCC AAC ACA AGG CTG ATC TGA PCR fragment of 440 bp (containing exon 1, 2 and 3 of Tff3, NM_011575) was amplified from mouse cochlea cDNA and cloned into pGEM-T vector (Promega) for in vitro transcription with T7-RNA-Polymerase (Roche) in the presence of Digoxygenin-UTP (DIG-UTP, Roche). The identity of clones was verified by cycle-sequencing using primers M13(-20): 5'-GTA AAA CGA CGG CCA GT-3' and M13 reverse: 5'-GGA AAC AGC TAT GAC CAT G-3' and performed on a Beckman CEQ2000 DNA Sequencer. To generate the riboprobe, plasmid DNA containing the full-length Tff3 cDNA was linearized with enzyme SpeI (New England Biolabs). The linearized DNA was purified by phenol-chloroform extraction and 1µg purified linear DNA was used as a template to synthesize digoxygenin-labeled riboprobes. Further on, DIG-labeled anti-sense probe was diluted in hybridization solution containing 25% mcroarray hybridization buffer (Amersham Biosciences), 25% nucleasefree water and 50% formamide (FA).
In situ hybridization with Tff3 riboprobes was performed as described [24] . Briefly, sections were incubated overnight at 58°C with the digoxigenin-labeled riboprobes that had been pre-heated at 65°C for 10 min. On the following day, they were washed in high-stringency 0.1 x SSC buffer, and then incubated with an anti-digoxygenin antibody conjugated to alkaline phosphatase. Substrate buffer containing nitro-bluetetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate was added to the sections and signal development was observed at different time periods. Once an appropriate signal was achieved, the sections were stopped simultaneously by immersion in water. Sections were mounted with Mowiol (Sigma) and viewed using an Olympus AX70 microscope. Hybridization was done in at least three different animals at a given age.
Auditory evoked brainstem responses
Audiograms were obtained from auditory evoked brainstem responses (ABR) recorded in anesthetized animals. Aesthesia was achieved by intraperitoneal injection of 50 mg/ kg ketamin hydrochloride (Ketamin 50 Curamed, CuraMED Pharma, Germany), 8 mg/kg xylazin hydrochloride (Rompun 290, Bayer Leverkusen, Germany) and 0.25 mg/kg atropin sulfate (Atropinsulfat, Braun, Germany). To record the ABR potentials, subdermal silver wire electrodes were inserted at the vertex (reference), ventrolateral to the measured ear (active) and at the back (ground) of the mice. Stimulus generation and response recordings were made using a National Instruments Multi IO Card (NI-PCI 6259). Electrical signals were averaged over 64 stimulus pairs after amplification (100 dB) and bandpass filtering (0.3-5 kHz). The software averager included an artifact rejection code (all waveforms with a peak to peak voltage exceeding a defined voltage were rejected) to eliminate the ECG and muscle activity. Sound pressure was calibrated in situ at all frequencies recorded prior to each measurement (Bruel & Kjaer 4135, Nexus amplifier). Recordings were carried out in a sound-proof chamber (IAC). Tone pips of alternating phase (3 ms, 1 ms rise and fall time, cosine-shaped, 60/sec, 2.0-32 kHz, 2 steps per 
Results
Tff3 expression in the cochlea, RT PCR
Reverse transcription PCR (RT-PCR) using cDNA reverse transcribed from RNA isolated from adult mice, indicated the presence of Tff3 in the colon and stomach (Fig. 1, lanes 3, 5, 6 ). Gel electrophoresis of the amplification products from the cochlea of the wild-type mouse and a mouse cochlear cDNA library resulted in identical signals (Fig. 1, lanes 1, 7) . It was missing in Tff3 deficient animals (Fig.1, lanes 2, 4) and in the negative control (Fig.1, lane 8) where no template was used.
Localization by in situ hybridization of Tff3 mRNA in the mouse cochlea
Using Tff3 in situ hybridization on cryosections, no Tff3 mRNA was detectable in the stria vascularis and spiral ligament (data not shown), organ of Corti (OC, Fig. (Fig. 2B, H) , of P17 (postnatal day 17) wild-type and Tff3 knock-out mice. The same negative results were obtained prior to the onset of hearing or > P17. Pronounced signals were however found in spiral ganglion neurons (SG, Fig. 2C, D) and also in vestibular ganglion neurons (VG, Fig. 2E, F) . As expected, the signal was missing in corresponding sections of Tff3 knock-out mice (Fig. 2I, J, 
2A, G) or vestibular hair cells (VHC)
and K, L).
Hearing function in Tff3 deficient mice At 3.5 weeks of age wild-type mice had an average ABR-audiogram with best thresholds of 29.0 (± 3.7, n=6) dB SPL at 16 kHz. Below this frequency average thresholds rose to 81.7 (± 3.7, n=6) dB SPL. At 2 kHz, average threshold at 32 kHz was 47.7 (± 2.5, n=6) dB SPL. In animals aged one year (n=3) a threshold loss of about 17 dB was found at and above 16 kHz. A 5 dB loss was found at low frequencies (Fig. 3A) .
At 3.5 weeks of age Tff3 knock-out mice had an average ABR-audiogram with best thresholds of 34.8 (± 5.5, n=13) dB SPL at 16 kHz. Below that frequency average thresholds rose to about 92.5 (± 2.6, n=13) dB SPL at 2 kHz, average threshold at 32 kHz was 63.3 (± 11.5, n=13) dB SPL. In animals aged one year (n=6) a 4 dB loss was found at low frequencies; it increased with a rate of about 10 dB/octave to a maximum of 38 dB at 22.6 kHz. Above that frequency, the hearing loss decreased to 27 dB. Thus, a higher age-related threshold loss in Tff3 knock-outs was clearly noted in comparison to wild-type animals (Fig. 3B) .
When ABR-thresholds in young wild-type and knock-out mice were assessed they revealed a hearing loss of 6 to 8 dB in the mid to high frequency range, and a hearing loss of about 15 dB at and below 8 kHz (Fig.  3C) . At one year of age the comparison of ABRthresholds between the wild-type and Tff3 knock-out mice showed a loss of about 15 dB at low frequencies increasing to 25 dB loss at higher frequencies (Fig. 3D) .
Middle ear morphology of Tff3 deficient mice
We carefully analysed the anatomy and function of the middle ear and the conductive apparatus. All elements of the middle ear, including the stape and position of the tympanic membrane, the middle ear cavity, the ossicular chain, the oval and round windows and the ostium of the eustathian tube were inspected. The integrity and function of the conductive apparatus was evaluated by the alternating pressure phenomenon. After application of alternating pressure to the umbo of the malleus proportionate movements of the round window membrane were visualized in both wild-type and Tff3 knock-out mice without any indication of impaired function.
Inner ear morphology of Tff3 wild-type and knock-out mice
To get a first insight how the lack of Tff3 is contributing to hearing loss we analysed the morphology of the cochlea using epoxy resin embedded (EPON) sections. We used older animals (at the age of 12 months) where a significant hearing loss was observed (Fig. 3D) . The fixation and embedding method was the same for wild-type and Tff3 knock-out mice.
Analysis of the inner ear structures of 12 months old wild-type and Tff3 knock-out mice (n=3 in each group) by light microscopy revealed a normal appearance of the cochlear duct, including the organ of Corti (compare Fig.  4A and G) , spiral ganglion (compare Fig. 4C, D and I, J) , stria vascularis (compare Fig. 4E and K) and crista ampullaris of the vestibular apparatus (compare Fig. 4F and L).
Discussion
In the present study we demonstrate a contribution of Tff3 for maintenance of normal hearing over age. Despite some indication of its function as a neuropeptide [11] , no involvement in the neurosensory systems has been described so far. We here present for the first time the expression of Tff3 in the mouse cochlea, confirmed by RT-PCR. Presently available four different Tff3 antibodies did not allow for a proper characterization of Tff3 expression in the inner ear that was elusive in Tff3 knock-out mice. Therefore the detection of mRNA was performed using in situ hybridization. Tff3 mRNA was localized in neurons of spiral ganglion and vestibular organ that was absent in Tff3 deficient mice, with deletion of the trefoil-domain-coding exon 2 of Tff3 gene [23] . Using auditory evoked brainstem responses (ABR) we observed a deterioration of hearing in Tff3 wild-type and deficient mice over age, most pronounced in the high frequency range (Fig. 3A and B) , a feature quite characteristic for presbyacusis (age related hearing loss) [25, 26] . However, high frequency hearing loss was more pronounced in the Tff3 knock-out mice than in the wild-type (Fig 3D) . Presbyacusis in humans is an age-related bilateral sensorineural hearing impairment associated with degeneration of cochlear hair cells and spiral ganglion cells (SGC) [27] [28] [29] [30] or atrophy of the stria vascularis [31] [32] [33] . To assess the contribution of Tff3 to the hearing process we at first analysed the morphology of the middle and inner ear in Tff3 knock-out mice. In summary no anatomical or functional abnormalities of the middle ear have been detected in Tff3 deficient animals as compared to the wild-type. Hence, the mechanics of middle ear sound conduction is not impaired. Analysis of the cochlear morphology of both wild-type and Tff3 knock-out animals revealed no obvious abnormalities in mutant mice. The position of Reissner's membrane, which delimits the scala media, was normal in both genotypes, indicating that salt and fluid secretion by the stria vascularis was not significantly impaired. The Reissner's membrane was tense in the wild-type and knock-out mice, indicating no Meniere-like vestibulocochlear symptoms [34] . The inner and outer hair cells as well as Deiter's cells appeared normal. The tectorial membrane had no conspicuous structure. The stria vascularis typically built from a three layer cell sheet: marginal, intermediate and basal cells [35] looked similar in both wild-type and knock-out mice pointing that progressive hearing loss observed in Tff3 knock-out mice is not due to shrinkage of the stria vascularis, a feature often observed in genetic mouse models with presbyacusis [36] . Crista ampullaris of the vestibular system did not show any structural changes nor were there any obvious signs of degeneration within or surround epithelia cells. Considering Tff3 expression in spiral ganglia it may be surprising that spiral ganglion neurons did not show any obvious changes in the quantity, in particular as a typical feature of age dependent hearing loss is the cell death of spiral ganglia neurons in high frequency cochlear turns [27] . However, more quantitative studies including counting of neurons will be required in the future. Different genes are involved in neuropathy which includes dysfunction of afferent nerves or glial cells [37, 38] . Auditory neuropathy was initially described as impairment of auditory neural function, with preserved cochlear hair cell function. The sites affected along the peripheral auditory pathway may include dysfunction of the synapse between hair cell and auditory nerve, and the auditory nerve fibres, with myelin as well as axonal impairments contributing to the disorder [37] . In this context a phenotype analysis of satellite cells, the glial cells surrounding cochlear neurons [39, 40] , as well as Schwann cells will be challenging in future analysis of Tff3 knock-out mice.In mice, the Tff gene cluster is localized on chromosome 17, a region synthenic with human 21q22.3. In human patients with progressive hearing impairment few chromosomal regions have been linked to this dysfunction [41] and a contribution of Tff3 to the complex genetic disorder of presbyacusis may be interesting to consider in the future. Until now TFF genes had not yet been reported as candidate genes for hearing disorders. On the basis of the present results a screening for linkage with 21q22.3 and TFF3 mutations could possibly become promising regarding the limited cohort group of patients with hearing loss.
Moreover, additional studies are needed to elucidate the structural and functional involvement of Tff3 in the neurosensory signal transmission. The physiological functions of trefoils are multiple. They enhance mucosal healing by promoting migration of epithelial cells whereas their expression in the brain suggests their possible function as neuropeptides [16] . Growing evidence supports the concept that immune reactions occur in the cochlea, where they can function either in protection or as a source of inflammation [42] . Recently published data about the role of trefoils in immune defense [43, 44] may suggest their possible role for the inner ear immunity. The transcription factor NFκB, known to be altered with immunoresponse, is commonly found in the inner ear, demonstrating the capability of the cochlea to respond to immunostimulation [45] . Additionally it is known that TFFs expression is strongly modulated by NFκB and down-regulated in case of prolonged inflammation [19] . TFFs are also able to modulate production of NO [46, 47] . Several studies suggest that nitric oxide (NO) plays an essential role in the pathophysiology of the inner ear including inflammation and immune response [48] . NO also regulate intracellular Ca 2+ -concentration in the inner and outer hair cells, thus influencing their mechanical properties as well as neurotransmission at synapses of the auditory nerve [49] . TFF's intricate regulatory pathways via cytokines and transcription factors and their participation in anti-apoptosis and innate immune response [50] and recently reviewed possible manifestation of UC in the nervous system [18] may serve as a lead for understanding their function in the inner ear.
